Fatty Liver Study in Patients With Type II Diabetes
Status:
Terminated
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to measure changes in hepatic lipid content using
three common alternative therapeutic strategies to improve glycemic control in patients with
type 2 diabetes who are not controlled with metformin alone.